The Province is providing $195M in funding in life sciences
Darpan News Desk The Canadian Press, 02 Mar, 2022 05:03 PM
The province is providing 195-million dollars in grant funding to help attract and retain top researchers in the life sciences field.
Jobs Minister Ravi Kahlon says Michael Smith Health Research B-C will get 116-million dollars while Genome BC will get the rest in order to spur innovation.
— Brenda Bailey, MLA (@BrendaBaileyBC) March 2, 2022
Kahlon says the province wants to leverage B-C's contributions to developing and manufacturing COVID-19 vaccines towards learning how to deal with future pandemics.
He says the funding could also help advance research in a range of areas including the development of new medications, rapid diagnostic tests for diseases and clean technology.Â
Statistics Canada reported Wednesday that the annual pace of inflation climbed in December to 4.8 per cent, a pace that hasn't been seen since September 1991.
Sean Fraser, Canada's minister responsible for refugees, says the latest arrivals are among a total of 7,000 refugees that have now been airlifted to various parts of Canada.
On January 19, 2022 shortly after 3:00 a.m. Surrey RCMP responded to the report of shots fired inside a warming center in the 10600-block of King George Boulevard. Two people were located with injuries believed to be gunshot wounds. Both victims were transported to hospital with non-life-threatening injuries and have since been released.
Environment and Climate Change Canada says in a news release that Hang Hing Herbal Medicine Ltd. was fined $75,000 for importing an endangered species without a permit.
Â
Â
There are 37,167 active cases of COVID-19 in the province, and 258,417 people who tested positive have recovered. Of the active cases, 854 COVID-positive individuals are in hospital and 112 are in intensive care. The remaining people are recovering at home in self-isolation.
Pronounced PAX-luh-vid, it is an oral antiviral treatment for COVID-19, consisting of a combination of two medications that must be taken together. The first drug, nirmatrelvir, blocks an enzyme that the SARS-CoV-2 virus needs to reproduce.Â
